title: Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature.
abstract: Although interferon has not been classified in the pathogenesis of sarcoidosis, it may rarely lead to this disease during treatment of chronic hepatitis C. The case of a 36-year-old woman with chronic hepatitis C who developed sarcoidosis within 10 weeks of treatment with recombinant interferon-alpha2a and ribavirin is described and all seven similar cases published in English from 1989 to 2001 are discussed.
authors.affiliation: Gastroenterology Institute, Marmara University, Istanbul, Turkey.
authors.forename: V
authors.initials: V
authors.lastname: Tahan
authors.forename: F
authors.initials: F
authors.lastname: Ozseker
authors.forename: D
authors.initials: D
authors.lastname: Guneylioglu
authors.forename: A
authors.initials: A
authors.lastname: Baran
authors.forename: R
authors.initials: R
authors.lastname: Ozaras
authors.forename: A
authors.initials: A
authors.lastname: Mert
authors.forename: A C
authors.initials: AC
authors.lastname: Ucisik
authors.forename: T
authors.initials: T
authors.lastname: Cagatay
authors.forename: D
authors.initials: D
authors.lastname: Yilmazbayhan
authors.forename: H
authors.initials: H
authors.lastname: Senturk
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin